| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | SLIT2 FBLN1 THBS4 FBN1 SCUBE2 LRP2 LRP4 PAM PRRG4 LTBP1 RET PCDH8 F12 NOTCH1 C2CD5 | 1.19e-06 | 749 | 90 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.13e-06 | 188 | 90 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | complement binding | 1.26e-05 | 32 | 90 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.90e-04 | 25 | 90 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 5.53e-04 | 8 | 90 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 8.83e-04 | 10 | 90 | 2 | GO:0001849 | |
| GeneOntologyBiologicalProcess | complement activation | 6.11e-07 | 70 | 90 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | kidney development | 5.13e-06 | 372 | 90 | 10 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 7.09e-06 | 386 | 90 | 10 | GO:0072001 | |
| GeneOntologyBiologicalProcess | humoral immune response | 1.12e-05 | 321 | 90 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 4.03e-05 | 44 | 90 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 5.69e-05 | 48 | 90 | 4 | GO:0043277 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 7.40e-05 | 19 | 90 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 7.73e-05 | 162 | 90 | 6 | GO:0072073 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.06e-04 | 107 | 90 | 5 | GO:0001657 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.12e-04 | 4 | 90 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.21e-04 | 110 | 90 | 5 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.21e-04 | 110 | 90 | 5 | GO:0072163 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.37e-04 | 113 | 90 | 5 | GO:0001823 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.56e-04 | 62 | 90 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | innate immune response | CFH MST1R DEFB105A NLRP10 WFDC2 DEFB127 TRIM62 C4A C4B C8A C8B FCN3 F12 TRIM10 | 2.61e-04 | 1092 | 90 | 14 | GO:0045087 |
| GeneOntologyBiologicalProcess | regulation of biological process involved in symbiotic interaction | 3.25e-04 | 75 | 90 | 4 | GO:0043903 | |
| GeneOntologyCellularComponent | extracellular matrix | CCN6 SLIT2 FBLN1 THBS4 ADAM19 FBN1 VWF LAMC1 LAMC3 MUC5B LTBP1 RTBDN FCN3 MUC5AC ADAMTSL4 F12 | 2.16e-08 | 656 | 91 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CCN6 SLIT2 FBLN1 THBS4 ADAM19 FBN1 VWF LAMC1 LAMC3 MUC5B LTBP1 RTBDN FCN3 MUC5AC ADAMTSL4 F12 | 2.25e-08 | 658 | 91 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | SLIT2 FBLN1 THBS4 ADAM19 FBN1 VWF LAMC1 LAMC3 LTBP1 RTBDN FCN3 ADAMTSL4 F12 | 4.87e-07 | 530 | 91 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | symbiont cell surface | 4.40e-06 | 8 | 91 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 6.58e-06 | 9 | 91 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | basement membrane | 1.94e-04 | 122 | 91 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | CFH MST1R SLIT2 ADAM19 VWF SCUBE2 LRP2 LRP4 PAM LY6K RTBDN BSN FCN3 NOTCH1 | 3.06e-04 | 1111 | 91 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | membrane attack complex | 3.88e-04 | 7 | 91 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | blood microparticle | 4.18e-04 | 144 | 91 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CFH SLIT2 KLHL24 RARA LRP2 LRP4 PAM C4A C4B LTBP1 RET BSN PCDH8 ASAP1 | 8.28e-04 | 1228 | 91 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | 1.24e-03 | 858 | 91 | 11 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.26e-03 | 860 | 91 | 11 | GO:0097447 | |
| GeneOntologyCellularComponent | microfibril | 1.42e-03 | 13 | 91 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 3.38e-03 | 20 | 91 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.39e-03 | 835 | 91 | 10 | GO:0043025 | |
| HumanPheno | Reduced circulating complement concentration | 4.02e-05 | 58 | 35 | 5 | HP:0004431 | |
| HumanPheno | Decreased circulating complement C8 concentration | 4.59e-05 | 2 | 35 | 2 | HP:0004434 | |
| HumanPheno | Abnormality of complement system | 5.14e-05 | 61 | 35 | 5 | HP:0005339 | |
| MousePheno | abnormal artery morphology | CFH SLIT2 FBLN1 CMIP ADAM19 FBN1 WFDC2 LRP2 PAM LTBP1 ODAD2 NOTCH1 | 2.63e-06 | 440 | 73 | 12 | MP:0002191 |
| MousePheno | abnormal thoracic aorta morphology | 6.12e-06 | 134 | 73 | 7 | MP:0010468 | |
| MousePheno | perimembraneous ventricular septal defect | 8.23e-06 | 92 | 73 | 6 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 8.76e-06 | 93 | 73 | 6 | MP:0008823 | |
| MousePheno | abnormal cyst | 2.13e-05 | 294 | 73 | 9 | MP:0031310 | |
| MousePheno | abnormal aorta morphology | 2.17e-05 | 225 | 73 | 8 | MP:0000272 | |
| MousePheno | abnormal aortic arch morphology | 3.59e-05 | 119 | 73 | 6 | MP:0004113 | |
| MousePheno | kidney cyst | 3.74e-05 | 177 | 73 | 7 | MP:0003675 | |
| MousePheno | muscular ventricular septal defect | 4.99e-05 | 77 | 73 | 5 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 5.64e-05 | 79 | 73 | 5 | MP:0010498 | |
| MousePheno | increased urine microglobulin level | 8.04e-05 | 3 | 73 | 2 | MP:0011555 | |
| MousePheno | abnormal systemic artery morphology | 1.80e-04 | 304 | 73 | 8 | MP:0011655 | |
| MousePheno | decreased spleen germinal center size | 1.96e-04 | 22 | 73 | 3 | MP:0008484 | |
| MousePheno | abnormal ureteric bud morphology | 2.19e-04 | 57 | 73 | 4 | MP:0006032 | |
| MousePheno | hydronephrosis | 2.59e-04 | 109 | 73 | 5 | MP:0000519 | |
| MousePheno | decreased spleen germinal center number | 3.26e-04 | 26 | 73 | 3 | MP:0008482 | |
| MousePheno | abnormal nephron morphology | 3.59e-04 | 426 | 73 | 9 | MP:0003881 | |
| MousePheno | ventricular septal defect | 4.16e-04 | 261 | 73 | 7 | MP:0010402 | |
| MousePheno | abnormal respiratory motile cilium morphology | 4.53e-04 | 29 | 73 | 3 | MP:0011050 | |
| MousePheno | abnormal kidney pelvis morphology | 4.70e-04 | 124 | 73 | 5 | MP:0004194 | |
| Domain | EGF-like_dom | ATRN SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 C8A C8B F12 NOTCH1 | 3.02e-15 | 249 | 90 | 17 | IPR000742 |
| Domain | EGF_1 | ATRN SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 C8A C8B F12 NOTCH1 | 4.48e-15 | 255 | 90 | 17 | PS00022 |
| Domain | EGF-like_CS | ATRN SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 C8A C8B F12 NOTCH1 | 6.59e-15 | 261 | 90 | 17 | IPR013032 |
| Domain | EGF_2 | ATRN SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 C8A C8B F12 NOTCH1 | 8.48e-15 | 265 | 90 | 17 | PS01186 |
| Domain | EGF_3 | ATRN SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 SCUBE2 LRP2 LRP4 LTBP1 C8A C8B F12 NOTCH1 | 3.98e-13 | 235 | 90 | 15 | PS50026 |
| Domain | Growth_fac_rcpt_ | CCN6 ATRN FBLN1 THBS4 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 C8A NOTCH1 | 5.48e-13 | 156 | 90 | 13 | IPR009030 |
| Domain | EGF | ATRN SLIT2 HGFAC FBLN1 THBS4 FBN1 SCUBE2 LRP2 LRP4 LAMC1 LAMC3 LTBP1 F12 NOTCH1 | 6.56e-12 | 235 | 90 | 14 | SM00181 |
| Domain | EGF_CA | 3.58e-10 | 122 | 90 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.21e-10 | 124 | 90 | 10 | IPR001881 | |
| Domain | EGF | 4.93e-10 | 126 | 90 | 10 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 9.40e-10 | 97 | 90 | 9 | IPR018097 | |
| Domain | EGF_CA | 1.13e-09 | 99 | 90 | 9 | PS01187 | |
| Domain | cEGF | 2.25e-09 | 26 | 90 | 6 | PF12662 | |
| Domain | cEGF | 2.25e-09 | 26 | 90 | 6 | IPR026823 | |
| Domain | EGF_CA | 8.27e-09 | 86 | 90 | 8 | PF07645 | |
| Domain | CTCK_1 | 1.89e-08 | 18 | 90 | 5 | PS01185 | |
| Domain | ASX_HYDROXYL | 2.74e-08 | 100 | 90 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.35e-08 | 106 | 90 | 8 | IPR000152 | |
| Domain | CT | 5.73e-08 | 22 | 90 | 5 | SM00041 | |
| Domain | Cys_knot_C | 1.14e-07 | 25 | 90 | 5 | IPR006207 | |
| Domain | CTCK_2 | 1.14e-07 | 25 | 90 | 5 | PS01225 | |
| Domain | TIL_dom | 4.86e-07 | 14 | 90 | 4 | IPR002919 | |
| Domain | TSP_1 | 5.76e-07 | 63 | 90 | 6 | PF00090 | |
| Domain | TSP1 | 6.95e-07 | 65 | 90 | 6 | SM00209 | |
| Domain | TSP1_rpt | 6.95e-07 | 65 | 90 | 6 | IPR000884 | |
| Domain | TSP1 | 6.95e-07 | 65 | 90 | 6 | PS50092 | |
| Domain | ANATO | 3.73e-06 | 7 | 90 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 3.73e-06 | 7 | 90 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.73e-06 | 7 | 90 | 3 | PS01177 | |
| Domain | ANATO | 3.73e-06 | 7 | 90 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 3.73e-06 | 7 | 90 | 3 | IPR000020 | |
| Domain | Coagulation_fac_XIIa/HGFA | 2.30e-05 | 2 | 90 | 2 | IPR014394 | |
| Domain | C8 | 2.31e-05 | 12 | 90 | 3 | PF08742 | |
| Domain | TIL | 2.31e-05 | 12 | 90 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.99e-05 | 13 | 90 | 3 | IPR014853 | |
| Domain | C8 | 2.99e-05 | 13 | 90 | 3 | SM00832 | |
| Domain | LDLR_class-A_CS | 4.04e-05 | 40 | 90 | 4 | IPR023415 | |
| Domain | Glyco_hormone_CN | 4.72e-05 | 15 | 90 | 3 | IPR006208 | |
| Domain | Cys_knot | 4.72e-05 | 15 | 90 | 3 | PF00007 | |
| Domain | VWF_type-D | 5.79e-05 | 16 | 90 | 3 | IPR001846 | |
| Domain | VWFD | 5.79e-05 | 16 | 90 | 3 | PS51233 | |
| Domain | VWD | 5.79e-05 | 16 | 90 | 3 | SM00216 | |
| Domain | VWD | 5.79e-05 | 16 | 90 | 3 | PF00094 | |
| Domain | Ldl_recept_a | 6.46e-05 | 45 | 90 | 4 | PF00057 | |
| Domain | LDLRA_1 | 8.34e-05 | 48 | 90 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 9.05e-05 | 49 | 90 | 4 | IPR002172 | |
| Domain | LDLa | 9.05e-05 | 49 | 90 | 4 | SM00192 | |
| Domain | LDLRA_2 | 9.05e-05 | 49 | 90 | 4 | PS50068 | |
| Domain | VWC_out | 9.92e-05 | 19 | 90 | 3 | SM00215 | |
| Domain | FN1_2 | 1.37e-04 | 4 | 90 | 2 | PS51091 | |
| Domain | fn1 | 1.37e-04 | 4 | 90 | 2 | PF00039 | |
| Domain | Fibronectin_type1 | 1.37e-04 | 4 | 90 | 2 | IPR000083 | |
| Domain | FN1 | 1.37e-04 | 4 | 90 | 2 | SM00058 | |
| Domain | FN1_1 | 1.37e-04 | 4 | 90 | 2 | PS01253 | |
| Domain | EGF_extracell | 2.00e-04 | 60 | 90 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.00e-04 | 60 | 90 | 4 | PF07974 | |
| Domain | Anaphylatoxin_comp_syst | 2.27e-04 | 5 | 90 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.27e-04 | 5 | 90 | 2 | IPR001840 | |
| Domain | VWC | 3.25e-04 | 28 | 90 | 3 | PF00093 | |
| Domain | MACPF_CS | 3.40e-04 | 6 | 90 | 2 | IPR020863 | |
| Domain | WxxW_domain | 3.40e-04 | 6 | 90 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.40e-04 | 6 | 90 | 2 | PF13330 | |
| Domain | EGF_LAM_2 | 4.00e-04 | 30 | 90 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 4.00e-04 | 30 | 90 | 3 | PS01248 | |
| Domain | TB | 4.75e-04 | 7 | 90 | 2 | PF00683 | |
| Domain | MACPF_2 | 4.75e-04 | 7 | 90 | 2 | PS51412 | |
| Domain | MACPF_1 | 4.75e-04 | 7 | 90 | 2 | PS00279 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 6.31e-04 | 8 | 90 | 2 | IPR019565 | |
| Domain | - | 6.31e-04 | 8 | 90 | 2 | 3.90.290.10 | |
| Domain | Thiol-ester_cl | 6.31e-04 | 8 | 90 | 2 | PF10569 | |
| Domain | LAMININ_IVA | 6.31e-04 | 8 | 90 | 2 | PS51115 | |
| Domain | Laminin_B | 6.31e-04 | 8 | 90 | 2 | PF00052 | |
| Domain | MacrogloblnA2_CS | 6.31e-04 | 8 | 90 | 2 | IPR019742 | |
| Domain | LamB | 6.31e-04 | 8 | 90 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.31e-04 | 8 | 90 | 2 | IPR000034 | |
| Domain | EGF_Lam | 6.33e-04 | 35 | 90 | 3 | SM00180 | |
| Domain | Laminin_EGF | 6.33e-04 | 35 | 90 | 3 | PF00053 | |
| Domain | VWFC_1 | 6.89e-04 | 36 | 90 | 3 | PS01208 | |
| Domain | VWFC_2 | 8.08e-04 | 38 | 90 | 3 | PS50184 | |
| Domain | VWC | 8.08e-04 | 38 | 90 | 3 | SM00214 | |
| Domain | Laminin_EGF | 8.08e-04 | 38 | 90 | 3 | IPR002049 | |
| Domain | TB_dom | 8.09e-04 | 9 | 90 | 2 | IPR017878 | |
| Domain | TB | 8.09e-04 | 9 | 90 | 2 | PS51364 | |
| Domain | - | 8.72e-04 | 39 | 90 | 3 | 2.120.10.30 | |
| Domain | MAC_perforin | 1.01e-03 | 10 | 90 | 2 | IPR001862 | |
| Domain | A2M | 1.01e-03 | 10 | 90 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.01e-03 | 10 | 90 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.01e-03 | 10 | 90 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.01e-03 | 10 | 90 | 2 | PF07677 | |
| Domain | A2M_comp | 1.01e-03 | 10 | 90 | 2 | PF07678 | |
| Domain | A2M_N | 1.01e-03 | 10 | 90 | 2 | PF01835 | |
| Domain | A2M_N | 1.01e-03 | 10 | 90 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.01e-03 | 10 | 90 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.01e-03 | 10 | 90 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.01e-03 | 10 | 90 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.01e-03 | 10 | 90 | 2 | IPR001599 | |
| Domain | VWF_dom | 1.08e-03 | 42 | 90 | 3 | IPR001007 | |
| Domain | Znf_RING_CS | 1.15e-03 | 163 | 90 | 5 | IPR017907 | |
| Domain | MACPF | 1.23e-03 | 11 | 90 | 2 | PF01823 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.41e-03 | 46 | 90 | 3 | IPR011042 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 6.84e-08 | 69 | 74 | 7 | M16894 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 1.58e-06 | 17 | 74 | 4 | MM15944 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 4.76e-06 | 22 | 74 | 4 | M39502 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.09e-05 | 96 | 74 | 6 | M39581 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.92e-05 | 106 | 74 | 6 | M42535 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 2.22e-05 | 11 | 74 | 3 | M47874 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.80e-05 | 68 | 74 | 5 | M27303 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.05e-05 | 115 | 74 | 6 | M19752 | |
| Pathway | KEGG_PRION_DISEASES | 3.24e-05 | 35 | 74 | 4 | M13036 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 3.82e-05 | 13 | 74 | 3 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 6.04e-05 | 15 | 74 | 3 | M7146 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 7.77e-05 | 84 | 74 | 5 | MM14653 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 9.66e-05 | 46 | 74 | 4 | M48243 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.48e-04 | 20 | 74 | 3 | M917 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.71e-04 | 300 | 74 | 8 | M610 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 2.40e-04 | 58 | 74 | 4 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 2.56e-04 | 59 | 74 | 4 | M48343 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 2.73e-04 | 60 | 74 | 4 | M40048 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 5.61e-04 | 7 | 74 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 5.61e-04 | 7 | 74 | 2 | M47873 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 7.46e-04 | 8 | 74 | 2 | M27031 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 7.46e-04 | 8 | 74 | 2 | M27006 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 7.46e-04 | 8 | 74 | 2 | M47872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 7.46e-04 | 8 | 74 | 2 | M47850 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 7.46e-04 | 8 | 74 | 2 | MM14656 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.20e-04 | 143 | 74 | 5 | M27275 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.49e-04 | 37 | 74 | 3 | M27134 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 9.56e-04 | 9 | 74 | 2 | M47881 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 9.83e-04 | 84 | 74 | 4 | M7098 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.22e-03 | 89 | 74 | 4 | M39398 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.45e-03 | 11 | 74 | 2 | MM1430 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 1.58e-03 | 44 | 74 | 3 | M39891 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.58e-03 | 44 | 74 | 3 | M26969 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.73e-03 | 12 | 74 | 2 | MM1368 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.79e-03 | 46 | 74 | 3 | M239 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.98e-03 | 250 | 74 | 6 | M27554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.37e-03 | 14 | 74 | 2 | M47834 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.57e-03 | 109 | 74 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.74e-03 | 111 | 74 | 4 | M27416 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.22e-09 | 248 | 92 | 10 | 24006456 | |
| Pubmed | 1.73e-09 | 257 | 92 | 10 | 16335952 | ||
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 2.86e-09 | 47 | 92 | 6 | 14760718 | |
| Pubmed | Functional analysis of Ficolin-3 mediated complement activation. | 7.15e-08 | 4 | 92 | 3 | 21085669 | |
| Pubmed | 1.78e-07 | 153 | 92 | 7 | 25037231 | ||
| Pubmed | 3.23e-07 | 167 | 92 | 7 | 22159717 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 16849499 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH ATRN FBLN1 THBS4 WFDC2 LRP2 PAM LAMC1 C4A C4B MUC5B C8A C8B F12 | 8.46e-07 | 1070 | 92 | 14 | 23533145 |
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 9.94e-07 | 8 | 92 | 3 | 32948785 | |
| Pubmed | 1.32e-06 | 71 | 92 | 5 | 33541421 | ||
| Pubmed | 1.49e-06 | 9 | 92 | 3 | 12122015 | ||
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 30429287 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 2.91e-06 | 11 | 92 | 3 | 23204401 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH MST1R ATRN FBLN1 FBN1 LRP4 PAM LAMC1 LAMC3 C4A LTBP1 LY6K USP48 NOTCH1 | 3.25e-06 | 1201 | 92 | 14 | 35696571 |
| Pubmed | 3.90e-06 | 40 | 92 | 4 | 23362348 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 19079262 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 22797898 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7513696 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 6.92e-06 | 2 | 92 | 2 | 16565498 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15998580 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19062096 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 37146737 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 6.92e-06 | 2 | 92 | 2 | 19933335 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31984663 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 6.92e-06 | 2 | 92 | 2 | 14988081 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 6.92e-06 | 2 | 92 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 6.92e-06 | 2 | 92 | 2 | 17645767 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23991205 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12207352 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15563276 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17621824 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24317696 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 6.92e-06 | 2 | 92 | 2 | 27758680 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22387014 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 6.92e-06 | 2 | 92 | 2 | 35776514 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 6.92e-06 | 2 | 92 | 2 | 23749435 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23918728 | ||
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 6.92e-06 | 2 | 92 | 2 | 28669633 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24327612 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 6.92e-06 | 2 | 92 | 2 | 3037333 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11726230 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 6.92e-06 | 2 | 92 | 2 | 6950384 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 6.92e-06 | 2 | 92 | 2 | 8428773 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 6.92e-06 | 2 | 92 | 2 | 21345967 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3171181 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 6.92e-06 | 2 | 92 | 2 | 28607090 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2572548 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2302180 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22151770 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 28684878 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 6.92e-06 | 2 | 92 | 2 | 18091514 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 29080553 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 6.92e-06 | 2 | 92 | 2 | 25339671 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17728371 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31030254 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 6149580 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 6149581 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 6.92e-06 | 2 | 92 | 2 | 23527003 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12115608 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3542363 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2387317 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16540890 | ||
| Pubmed | Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients. | 6.92e-06 | 2 | 92 | 2 | 20564469 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16908004 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7365238 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 6.92e-06 | 2 | 92 | 2 | 27845589 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7391573 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 6.92e-06 | 2 | 92 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 6.92e-06 | 2 | 92 | 2 | 17971229 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 6881182 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27435107 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26871672 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 6.92e-06 | 2 | 92 | 2 | 17921792 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 6.92e-06 | 2 | 92 | 2 | 6978711 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 35898513 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 28873507 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7440581 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 6.92e-06 | 2 | 92 | 2 | 6832377 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3794341 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 6.92e-06 | 2 | 92 | 2 | 11587997 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22785613 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24014239 | ||
| Pubmed | A genotype-phenotype comparison of ADAMTSL4 and FBN1 in isolated ectopia lentis. | 6.92e-06 | 2 | 92 | 2 | 22736615 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 6.92e-06 | 2 | 92 | 2 | 8390682 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 6.92e-06 | 2 | 92 | 2 | 34656442 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 6.92e-06 | 2 | 92 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 6.92e-06 | 2 | 92 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 6.92e-06 | 2 | 92 | 2 | 3696167 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 34058148 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 6.92e-06 | 2 | 92 | 2 | 1357031 | |
| Interaction | NTN5 interactions | 6.67e-08 | 24 | 91 | 5 | int:NTN5 | |
| Interaction | ZFP41 interactions | 2.16e-07 | 57 | 91 | 6 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 2.26e-05 | 75 | 91 | 5 | int:IGFL3 | |
| GeneFamily | Complement system|Sushi domain containing | 2.07e-07 | 36 | 67 | 5 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.79e-04 | 9 | 67 | 2 | 1234 | |
| GeneFamily | Laminin subunits | 8.72e-04 | 12 | 67 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 1.03e-03 | 13 | 67 | 2 | 634 | |
| GeneFamily | CD molecules|Mucins | 2.71e-03 | 21 | 67 | 2 | 648 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH FZD8 CCN6 SLIT2 FBLN1 FBN1 NALCN NPB WFDC2 ARHGEF10 LAMC1 TNFRSF19 LIMCH1 LY6K THSD7B PLEKHH2 PDZRN4 | 1.29e-09 | 767 | 92 | 17 | M39209 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.48e-08 | 191 | 92 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.09e-08 | 196 | 92 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME | CCN6 SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 VWF SCUBE2 LAMC1 LAMC3 MUC5B LTBP1 FCN3 MUC5AC ADAMTSL4 F12 | 9.24e-08 | 1026 | 92 | 17 | M5889 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CFH FBLN1 ADAM19 FBN1 VWF SCUBE2 ADGRB3 PAM LAMC1 LAMC3 LIMCH1 ASAP1 | 2.06e-07 | 505 | 92 | 12 | M39167 |
| Coexpression | NABA_MATRISOME | CCN6 SLIT2 HGFAC FBLN1 THBS4 ADAM19 FBN1 VWF SCUBE2 LAMC1 LAMC3 MUC5B LTBP1 MUC5AC ADAMTSL4 F12 | 4.12e-07 | 1008 | 92 | 16 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 4.71e-07 | 270 | 92 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 5.49e-07 | 275 | 92 | 9 | M5884 | |
| Coexpression | HALLMARK_COAGULATION | 9.39e-06 | 138 | 92 | 6 | M5946 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 1.02e-04 | 211 | 92 | 6 | M12225 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | SLIT2 FBLN1 HNF1B FBN1 WFDC2 LRP2 LRP4 LAMC1 PRRG4 LTBP1 PLEKHH2 NOTCH1 ASAP1 | 2.85e-05 | 783 | 91 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.89e-05 | 83 | 91 | 5 | gudmap_kidney_P2_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 5.27e-05 | 398 | 91 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.11e-05 | 97 | 91 | 5 | GSM777043_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.07e-04 | 175 | 91 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.23e-04 | 445 | 91 | 9 | GSM777043_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.46e-04 | 62 | 91 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.74e-04 | 466 | 91 | 9 | GSM777050_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.75e-04 | 65 | 91 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.90e-04 | 370 | 91 | 8 | gudmap_kidney_P3_CapMes_Crym_500 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SLIT2 FBLN1 FBN1 SCUBE2 LAMC1 TNFRSF19 LTBP1 LIMCH1 PLEKHH2 | 4.95e-12 | 182 | 92 | 10 | c557de6ccd327c46e0a5423cd9936d78e0abae5f |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SLIT2 FBLN1 FBN1 SCUBE2 LAMC1 TNFRSF19 LTBP1 LIMCH1 PLEKHH2 | 4.95e-12 | 182 | 92 | 10 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.97e-10 | 187 | 92 | 9 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-10 | 189 | 92 | 9 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-10 | 191 | 92 | 9 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-10 | 191 | 92 | 9 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-10 | 191 | 92 | 9 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-10 | 191 | 92 | 9 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-10 | 191 | 92 | 9 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-10 | 191 | 92 | 9 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.49e-10 | 192 | 92 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.61e-10 | 193 | 92 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.42e-10 | 199 | 92 | 9 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-09 | 168 | 92 | 8 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.29e-09 | 176 | 92 | 8 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.28e-09 | 182 | 92 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-09 | 189 | 92 | 8 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-09 | 190 | 92 | 8 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-09 | 190 | 92 | 8 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-09 | 190 | 92 | 8 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.25e-09 | 191 | 92 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Lung-21m-Mesenchymal|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-09 | 191 | 92 | 8 | 10a9db1caa0fdb51ace8537f42b2c66f7c97e0f5 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 192 | 92 | 8 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 6.51e-09 | 192 | 92 | 8 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 192 | 92 | 8 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-09 | 193 | 92 | 8 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-09 | 193 | 92 | 8 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.78e-09 | 193 | 92 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 7.06e-09 | 194 | 92 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.06e-09 | 194 | 92 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-09 | 196 | 92 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.96e-09 | 197 | 92 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.28e-09 | 198 | 92 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-09 | 200 | 92 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-09 | 200 | 92 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-08 | 179 | 92 | 7 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-08 | 180 | 92 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.60e-08 | 180 | 92 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.97e-08 | 181 | 92 | 7 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.97e-08 | 181 | 92 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 182 | 92 | 7 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 182 | 92 | 7 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 182 | 92 | 7 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.24e-07 | 187 | 92 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.24e-07 | 187 | 92 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-07 | 188 | 92 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 189 | 92 | 7 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-07 | 189 | 92 | 7 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 189 | 92 | 7 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-07 | 189 | 92 | 7 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-07 | 189 | 92 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-07 | 189 | 92 | 7 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 190 | 92 | 7 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.39e-07 | 190 | 92 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-07 | 191 | 92 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-07 | 191 | 92 | 7 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 192 | 92 | 7 | df56c3e3bb1aafc1126607f4426554c09c8c40cf | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-07 | 192 | 92 | 7 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 192 | 92 | 7 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 1.54e-07 | 193 | 92 | 7 | f31398dad5321a7bcb27e208bd73630e9756e897 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-07 | 193 | 92 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 193 | 92 | 7 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-07 | 193 | 92 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 193 | 92 | 7 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-07 | 193 | 92 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.54e-07 | 193 | 92 | 7 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 194 | 92 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.60e-07 | 194 | 92 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 194 | 92 | 7 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.60e-07 | 194 | 92 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-07 | 194 | 92 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.60e-07 | 194 | 92 | 7 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.65e-07 | 195 | 92 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.65e-07 | 195 | 92 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-07 | 195 | 92 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.65e-07 | 195 | 92 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-07 | 195 | 92 | 7 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-07 | 195 | 92 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-07 | 195 | 92 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-07 | 195 | 92 | 7 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-07 | 195 | 92 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| Computational | Metal / Ca ion binding. | 4.69e-06 | 133 | 55 | 7 | MODULE_324 | |
| Computational | Complement. | 5.05e-06 | 23 | 55 | 4 | MODULE_130 | |
| Computational | Neighborhood of HPX | 3.36e-05 | 73 | 55 | 5 | CAR_HPX | |
| Computational | Genes in the cancer module 58. | 1.58e-04 | 21 | 55 | 3 | MODULE_58 | |
| Computational | Neighborhood of IGFBP1 | 1.98e-04 | 57 | 55 | 4 | CAR_IGFBP1 | |
| Computational | ECM and collagens. | 9.69e-04 | 225 | 55 | 6 | MODULE_47 | |
| Computational | Trachea genes. | 1.14e-03 | 415 | 55 | 8 | MODULE_6 | |
| Drug | Rgd Peptide | 5.43e-07 | 239 | 92 | 9 | CID000104802 | |
| Drug | AC1NE3ZR | 3.49e-06 | 26 | 92 | 4 | CID004636208 | |
| Drug | I-hu | 1.03e-05 | 11 | 92 | 3 | CID009547901 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | 1.30e-05 | 192 | 92 | 7 | 611_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.44e-05 | 195 | 92 | 7 | 5736_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 2308_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 7034_DN | |
| Drug | Grgds | 2.19e-05 | 83 | 92 | 5 | CID000123811 | |
| Disease | Complement deficiency disease | 6.58e-10 | 33 | 89 | 6 | C0272242 | |
| Disease | Antibody Deficiency Syndrome | 1.34e-09 | 17 | 89 | 5 | C0003257 | |
| Disease | Immunologic Deficiency Syndromes | 7.18e-09 | 23 | 89 | 5 | C0021051 | |
| Disease | neurexophilin-1 measurement | 1.47e-06 | 8 | 89 | 3 | EFO_0008244 | |
| Disease | Ectopia Lentis | 9.00e-06 | 2 | 89 | 2 | C0013581 | |
| Disease | tumor necrosis factor receptor superfamily member 19 measurement | 9.00e-06 | 2 | 89 | 2 | EFO_0020808 | |
| Disease | Ectopia lentis isolated | 9.00e-06 | 2 | 89 | 2 | C1851286 | |
| Disease | Familial ectopia lentis | 9.00e-06 | 2 | 89 | 2 | C2746069 | |
| Disease | Isolated ectopia lentis | 9.00e-06 | 2 | 89 | 2 | cv:C1851286 | |
| Disease | Ectopia lentis | 9.00e-06 | 2 | 89 | 2 | cv:C0013581 | |
| Disease | Neisseriaceae Infections | 2.69e-05 | 3 | 89 | 2 | C0085396 | |
| Disease | Pachymeningitis | 2.69e-05 | 3 | 89 | 2 | C0030167 | |
| Disease | Meningitis | 2.69e-05 | 3 | 89 | 2 | C0025289 | |
| Disease | glycoprotein measurement | 3.11e-05 | 119 | 89 | 5 | EFO_0004555 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.28e-05 | 64 | 89 | 4 | DOID:4947 (is_marker_for) | |
| Disease | toll-like receptor 2 measurement | 5.38e-05 | 4 | 89 | 2 | EFO_0020777 | |
| Disease | septin-10 measurement | 5.38e-05 | 4 | 89 | 2 | EFO_0802053 | |
| Disease | syntaxin-1a measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0020759 | |
| Disease | cyclin-H measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0801508 | |
| Disease | matrix extracellular phosphoglycoprotein measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0020557 | |
| Disease | progonadoliberin-1 measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0801924 | |
| Disease | CD63 antigen measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0022033 | |
| Disease | NKG2-E type II integral membrane protein measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0801842 | |
| Disease | serine/threonine-protein kinase ULK3 measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0803065 | |
| Disease | semenogelin-1 measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0802051 | |
| Disease | glucosidase 2 subunit beta measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0801628 | |
| Disease | cadherin-15 measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0020211 | |
| Disease | C-C motif chemokine 1 measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0008041 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 2.49e-04 | 8 | 89 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | sulfatase-modifying factor 1 measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0802098 | |
| Disease | Marfan Syndrome, Type I | 3.19e-04 | 9 | 89 | 2 | C4721845 | |
| Disease | complement component C8 measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0008094 | |
| Disease | Fuchs endothelial corneal dystrophy | 3.98e-04 | 10 | 89 | 2 | Orphanet_98974 | |
| Disease | bone morphogenetic protein 7 measurement | 3.98e-04 | 10 | 89 | 2 | EFO_0020187 | |
| Disease | transmembrane glycoprotein NMB measurement | 3.98e-04 | 10 | 89 | 2 | EFO_0008303 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 3.98e-04 | 10 | 89 | 2 | EFO_0008321 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.69e-04 | 50 | 89 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | PR domain zinc finger protein 1 measurement | 4.86e-04 | 11 | 89 | 2 | EFO_0801904 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 4.86e-04 | 11 | 89 | 2 | EFO_0801871 | |
| Disease | pulmonary fibrosis | 4.86e-04 | 11 | 89 | 2 | EFO_0009448 | |
| Disease | Marfan Syndrome | 4.86e-04 | 11 | 89 | 2 | C0024796 | |
| Disease | transmembrane protein 87B measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0802158 | |
| Disease | idiopathic pulmonary fibrosis | 6.90e-04 | 57 | 89 | 3 | EFO_0000768 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 8.00e-04 | 14 | 89 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 8.00e-04 | 14 | 89 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 19 measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0008047 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 8.82e-04 | 62 | 89 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | mannan-binding lectin serine protease 1 measurement | 9.21e-04 | 15 | 89 | 2 | EFO_0008223 | |
| Disease | Proteinuria | 9.21e-04 | 15 | 89 | 2 | HP_0000093 | |
| Disease | coronary artery disease | BSND HGFAC DPYD CMIP ADAM19 DEFB127 LAMC1 PLEKHH2 BSN USP48 ABCC10 | 9.25e-04 | 1194 | 89 | 11 | EFO_0001645 |
| Disease | interstitial lung disease | 1.11e-03 | 67 | 89 | 3 | EFO_0004244 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.11e-03 | 67 | 89 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.20e-03 | 69 | 89 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | prostate carcinoma | 1.47e-03 | 891 | 89 | 9 | EFO_0001663 | |
| Disease | glaucoma (is_marker_for) | 1.65e-03 | 20 | 89 | 2 | DOID:1686 (is_marker_for) | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.65e-03 | 20 | 89 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | coagulation factor measurement | 1.65e-03 | 20 | 89 | 2 | EFO_0004634 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.00e-03 | 22 | 89 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | mental or behavioural disorder | 2.14e-03 | 179 | 89 | 4 | EFO_0000677 | |
| Disease | vitronectin measurement | 2.18e-03 | 23 | 89 | 2 | EFO_0021843 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 2.18e-03 | 23 | 89 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.66e-03 | 91 | 89 | 3 | EFO_0004611, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGDTQNCQLRCRDRD | 36 | Q9UK28 | |
| NCQLRCRDRDLGPQP | 41 | Q9UK28 | |
| NECLGGVPECRDLQV | 261 | O14867 | |
| ADCCRIQLQLPGKQD | 806 | O15013 | |
| QDVAGRGCCRDPNAQ | 406 | A0A096LP49 | |
| EVQGSQRCELNCRPR | 411 | Q6UY14 | |
| CRAGIQERRRECDNP | 551 | P07357 | |
| CEQRAARVQQPDCRE | 716 | P0C0L5 | |
| GEEVRRCNEQRCPAP | 496 | O60242 | |
| DAFRCRLRNCQDPIN | 1156 | O60242 | |
| GTLCREQARQCDLPE | 471 | Q9H013 | |
| SLKEIRNGCQQPCDR | 351 | Q8IY22 | |
| GQLCVADRENGRIQC | 696 | P19021 | |
| GLACGQDPELVRNIC | 681 | Q12882 | |
| ELLQRPGNARCADCG | 11 | O75689 | |
| EPRARRVQCNRCNEV | 241 | O95376 | |
| CVAEDCNELPPRRNT | 16 | P08603 | |
| ECDLNRQCGVINPET | 236 | Q5T6C5 | |
| VCEQPLGLECRAQAQ | 2351 | Q9HC84 | |
| CIGNPDEDCERFRQL | 616 | Q6ZMN7 | |
| VRCQQRNCIPIGEQL | 211 | Q9H8K7 | |
| AICLICGDRQDLEQP | 331 | P10276 | |
| CIRVLCIGNENNQRA | 846 | Q7Z5J8 | |
| NLDREVCSRCGQPVD | 66 | Q8IYY4 | |
| VNLLRCQEGPRNCRE | 81 | O75636 | |
| CQEGPRNCRELLSQG | 86 | O75636 | |
| GACGELRQPQDICRL | 236 | Q5T3U5 | |
| DPQIAICLDCLRNNG | 136 | Q86SE9 | |
| RQDVNECGQKPGLCR | 176 | P46531 | |
| CERENTFECQNPRRC | 46 | Q17RY6 | |
| PVGDCDFNVRLQCIE | 371 | O60942 | |
| CCGDNQAPVTEILRQ | 226 | Q86W26 | |
| EANEELRCAQLQPRG | 416 | Q96ED9 | |
| RNQECIALPENICGI | 776 | O75882 | |
| ECQLCEVENRYQGNP | 1136 | O75882 | |
| ERAICPLCQAELNVG | 461 | Q9UPA5 | |
| TQRGRCEDIDECLNP | 991 | Q14766 | |
| DRERLCGQAPQCVLA | 91 | O95206 | |
| NQIANELCECPELLG | 606 | P48506 | |
| ECLENEKPDGNCRLN | 56 | Q8NG35 | |
| ANGEDCLNQVCRRLG | 21 | Q8WY64 | |
| QRACQCEGKDNRIPL | 121 | Q8N9F7 | |
| PRECTESEFRCVNQQ | 3756 | P98164 | |
| CSREEGLVCRNQDQQ | 1811 | P98088 | |
| CSREEGLVCRNQDQQ | 4021 | P98088 | |
| ICRVNEVPEALCENG | 36 | Q9H1M4 | |
| RLCNIEPDERCFLGN | 276 | Q04756 | |
| RGDPCNTICCREDLN | 466 | Q6P4A8 | |
| DGCSEEQLRQLCQRL | 1306 | Q8IVE3 | |
| IRDLCQARDCQNPNA | 426 | Q5T6X5 | |
| LAPNGRNCQDIDECV | 516 | P23142 | |
| VCQRNCREPGDIFSE | 336 | O95389 | |
| NCPCLRDLQPDQARR | 566 | Q9H461 | |
| EQLDPCNCLGIQRFA | 161 | Q6TFL4 | |
| QEPQGCRCPLDRFQD | 226 | Q8WZ55 | |
| IDECLQNGRICNNGR | 531 | P35555 | |
| LLDPRTQQECAQCGV | 246 | Q9BVV2 | |
| IIEDVQRLPGNDICC | 441 | Q9ULH1 | |
| RRLCLALDEPQLCNG | 1236 | O75064 | |
| RLCQCSDNIDPNAVG | 826 | P11047 | |
| RERCILCPNGTFQNE | 651 | Q9NQ36 | |
| EQRLEENLPTRCGFC | 451 | Q86YS7 | |
| GRCVNRRLLCNGDND | 131 | P07358 | |
| AQRCGQGACRREDPQ | 441 | Q2VPK5 | |
| QGACRREDPQACIEE | 446 | Q2VPK5 | |
| CEQRAARVQQPDCRE | 716 | P0C0L4 | |
| TDVRIRNGLLNCNDC | 1056 | Q9UPQ0 | |
| EECNRAECLQRGVSP | 266 | P35680 | |
| VLGQERRNHSCEPCQ | 426 | P00748 | |
| LGVRQAQPLCEELCQ | 106 | Q9BSG5 | |
| RQAPEGALCQDCVRQ | 176 | Q6NUJ1 | |
| VVGALGECCQERENR | 776 | Q5T2S8 | |
| APQEQEELLECRRRC | 66 | B7ZBB8 | |
| CVQDVAPNLQRCERL | 86 | Q8NG41 | |
| RGCKAERNCRNPELN | 416 | P35443 | |
| NFPQLGLCRDQCQVD | 86 | Q14508 | |
| CPQSCEERNLRENGY | 1126 | P04275 | |
| VCDMCGNGRLEQRPE | 796 | Q14159 | |
| DCPNCQELERLGAAA | 271 | Q8TDD2 | |
| QNGAQCIVRINEPIC | 1131 | O94813 | |
| TPGNLERECNEELCN | 61 | Q9BZD6 | |
| QDINICPQDCLRGSI | 576 | P07949 | |
| VCAQCLRNGQVIEPD | 711 | Q8IWR0 | |
| QRCENRLECNGAISA | 56 | Q09FC8 | |
| QQEFRDRSGNCVPCN | 36 | Q9NS68 | |
| ADEVNCPICQGTLRE | 11 | Q9UDY6 | |
| EQLRECGFLRTPEQC | 536 | Q63HK3 | |
| CHQQLQELEEGCRPE | 116 | O15482 | |
| EACIVEGELLQQCPR | 386 | Q9C0I4 | |
| CPECREGLLCQQQRD | 841 | Q86UV5 | |
| EEDCRLNGPQKQDLC | 111 | Q6IV72 | |
| RQEAQGARDCPECRR | 41 | Q9BVG3 | |
| ESRCERQLPEQQLCR | 811 | Q04912 | |
| LQAVDNEGNPLCLRC | 901 | Q5FWF4 | |
| RPCESNECGNAIRQN | 271 | Q86TJ5 | |
| TLIQGLNECCNVRPE | 691 | Q96M32 | |
| KENVEGNLCDRCRPG | 451 | Q9Y6N6 | |
| QQNCRPRTGEENCNV | 346 | O75096 | |
| CNDPNIIRREDCNGI | 1046 | Q8IZF0 |